• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述克罗恩病患者口腔、痰液和回肠微生物群的特定特征。

Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease.

机构信息

Diagnostic and Treatment Center for Refractory Diseases of Abdomen Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Biochemistry, Medical University of Lodz, Lodz, Poland.

出版信息

Front Cell Infect Microbiol. 2022 Apr 13;12:864944. doi: 10.3389/fcimb.2022.864944. eCollection 2022.

DOI:10.3389/fcimb.2022.864944
PMID:35493739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9045729/
Abstract

BACKGROUND

Crohn's disease (CD) is a chronic nonspecific inflammatory bowel disease (IBD) with an increasing incidence worldwide. The etiology of CD is still obscure, but microbial dysbiosis has been recognized as an essential factor contributing to CD. However, few studies have revealed the microbiome's signatures and reciprocal correlations between multiple sites in patients with CD over different disease stages. This study investigated the specific microbial architectures of the oral cavity, sputum, and ileum in patients with CD in the active and remission stages.

METHODS

Microbial samples from the oral cavity, sputum, and ileum were collected from patients with CD in the active and remission stages and healthy controls. The microbial composition was assessed by 16S ribosomal RNA (rRNA) gene sequencing. In addition, bioinformatics methods were used to demonstrate the microbial signatures, functional changes, and correlations between microbiota and clinical data in CD.

RESULTS

Compared with healthy controls, a distinct microbiota dysbiosis in the oral cavity, sputum, and ileum of patients with CD was identified, characterized by alterations in microbiota biodiversity and composition. The oral cavity and sputum microbiota showed significantly lower microbial diversity in patients with CD than in healthy controls. In terms of microbiota composition, the microbiota changes in the oral cavity of patients with CD were similar to those in the sputum, while they were different from those in the ileum. In the oral cavity and sputum of patients with CD, a lower relative abundance of and was observed compared to healthy controls, which was most prominent in the active stage. In contrast, an increased relative abundance of , , and was observed in patients with CD. The predicted metabolic pathways involved in the oral cavity, sputum, and ileum were similar, predominantly involving metabolism, environmental information processing, and genetic information processing.

CONCLUSION

The results revealed the alterations of microbiota architecture in the oral cavity, sputum, and ileum of patients with CD, which varied across disease stages. Studying microbiota dysbiosis may bring new insights into the etiology of CD and lead to novel treatments.

摘要

背景

克罗恩病(CD)是一种慢性非特异性炎症性肠病(IBD),全球发病率呈上升趋势。CD 的病因仍不清楚,但微生物失调已被认为是导致 CD 的一个重要因素。然而,很少有研究揭示 CD 患者在不同疾病阶段多个部位的微生物组特征和相互关联。本研究调查了活动期和缓解期 CD 患者口腔、痰和回肠的特定微生物结构。

方法

收集活动期和缓解期 CD 患者和健康对照者的口腔、痰和回肠微生物样本,通过 16S 核糖体 RNA(rRNA)基因测序评估微生物组成。此外,还使用生物信息学方法展示 CD 患者微生物组特征、功能变化以及微生物组与临床数据之间的相关性。

结果

与健康对照组相比,CD 患者口腔、痰和回肠的微生物群明显失调,表现为微生物多样性和组成的改变。CD 患者口腔和痰中的微生物多样性明显低于健康对照组。就微生物组成而言,CD 患者口腔的微生物变化与痰相似,而与回肠不同。在 CD 患者的口腔和痰中,观察到相对丰度较低的 和 ,在活动期最为明显。相比之下,观察到相对丰度较高的 、 、 。口腔、痰和回肠中涉及的预测代谢途径相似,主要涉及代谢、环境信息处理和遗传信息处理。

结论

结果揭示了 CD 患者口腔、痰和回肠的微生物群结构改变,且在疾病阶段有所不同。研究微生物群失调可能为 CD 的病因提供新的见解,并为新的治疗方法提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/6096a377c0b2/fcimb-12-864944-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/ef2d468bddf6/fcimb-12-864944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/2ab642a3313b/fcimb-12-864944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/91c6a9e95e87/fcimb-12-864944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/67d2a8c1d9ea/fcimb-12-864944-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/28d04a2bab56/fcimb-12-864944-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/9a28bc7aa1b2/fcimb-12-864944-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/83730aa60568/fcimb-12-864944-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/6096a377c0b2/fcimb-12-864944-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/ef2d468bddf6/fcimb-12-864944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/2ab642a3313b/fcimb-12-864944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/91c6a9e95e87/fcimb-12-864944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/67d2a8c1d9ea/fcimb-12-864944-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/28d04a2bab56/fcimb-12-864944-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/9a28bc7aa1b2/fcimb-12-864944-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/83730aa60568/fcimb-12-864944-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/207f/9045729/6096a377c0b2/fcimb-12-864944-g008.jpg

相似文献

1
Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease.描述克罗恩病患者口腔、痰液和回肠微生物群的特定特征。
Front Cell Infect Microbiol. 2022 Apr 13;12:864944. doi: 10.3389/fcimb.2022.864944. eCollection 2022.
2
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?韩国克罗恩病患者的肠道微生物群落与西方患者的不同吗?
BMC Gastroenterol. 2016 Feb 29;16:28. doi: 10.1186/s12876-016-0437-0.
3
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.克罗恩病粪便宏基因组的调控:miRNAs 作为生物标志物的作用。
World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.
4
Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.解析不同因素导致肠道菌群失调的克罗恩病患者的唾液微生物组特征。
Sci Rep. 2023 Nov 6;13(1):19198. doi: 10.1038/s41598-023-46714-8.
5
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.分析内镜刷取样本发现炎症性肠病存在黏膜相关的菌群失调。
J Gastroenterol. 2018 Jan;53(1):95-106. doi: 10.1007/s00535-017-1384-4. Epub 2017 Aug 29.
6
Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.克罗恩病治疗过程中黏膜相关肠道微生物群的特征。
World J Gastroenterol. 2019 May 14;25(18):2204-2216. doi: 10.3748/wjg.v25.i18.2204.
7
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
8
Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.克罗恩病相关先天免疫功能多态性对回肠微生物组的影响。
PLoS One. 2019 Feb 28;14(2):e0213108. doi: 10.1371/journal.pone.0213108. eCollection 2019.
9
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.炎症相关的黏膜相关微生物群和肠道屏障功能在结肠克罗恩病中的差异。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G420-G431. doi: 10.1152/ajpgi.00411.2017. Epub 2018 May 31.
10
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.克罗恩病患者粪便微生物群落中产生丁酸盐的细菌种类丰度降低
Digestion. 2016;93(1):59-65. doi: 10.1159/000441768. Epub 2016 Jan 14.

引用本文的文献

1
Distribution of gut microbiota across intestinal segments and their impact on human physiological and pathological processes.肠道微生物群在肠道各段的分布及其对人类生理和病理过程的影响。
Cell Biosci. 2025 Apr 16;15(1):47. doi: 10.1186/s13578-025-01385-y.
2
The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight.炎症性肠病中的口-肠道微生物轴:从内部到深入了解。
Front Immunol. 2024 Jul 26;15:1430001. doi: 10.3389/fimmu.2024.1430001. eCollection 2024.
3
Isolation, identification, and significance of salivary spp., spp., and in patients with inflammatory bowel disease.

本文引用的文献

1
The lung microbiota in children with cystic fibrosis captured by induced sputum sampling.儿童囊性纤维化患者诱导痰样本中的肺部微生物组。
J Cyst Fibros. 2022 Nov;21(6):1006-1012. doi: 10.1016/j.jcf.2022.01.006. Epub 2022 Jan 22.
2
The role of oral bacteria in inflammatory bowel disease.口腔细菌在炎症性肠病中的作用。
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):731-742. doi: 10.1038/s41575-021-00488-4. Epub 2021 Aug 16.
3
Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.
炎症性肠病患者唾液中 spp.、 spp. 和 的分离鉴定及意义。
Front Cell Infect Microbiol. 2023 Nov 20;13:1278582. doi: 10.3389/fcimb.2023.1278582. eCollection 2023.
4
Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases.解析肠道和口腔微生物组对炎症性肠病肠道健康的影响。
Nutrients. 2023 Jul 29;15(15):3377. doi: 10.3390/nu15153377.
5
Influence of Gallic Acid-Containing Mouth Spray on Dental Health and Oral Microbiota of Healthy Dogs: A Pilot Study.含没食子酸口腔喷雾剂对健康犬牙齿健康和口腔微生物群的影响:一项初步研究。
Vet Sci. 2023 Jun 30;10(7):424. doi: 10.3390/vetsci10070424.
6
Timing of individualized surgical intervention in Crohn's disease.克罗恩病个体化手术干预的时机
World J Gastrointest Surg. 2022 Dec 27;14(12):1320-1328. doi: 10.4240/wjgs.v14.i12.1320.
肠道细菌和病毒在结直肠癌中的改变、相互作用和诊断潜力。
Front Cell Infect Microbiol. 2021 Jul 6;11:657867. doi: 10.3389/fcimb.2021.657867. eCollection 2021.
4
Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome.生酮饮食通过改变肠道微生物组减少结肠 3 组固有淋巴细胞从而缓解结肠炎。
Signal Transduct Target Ther. 2021 Apr 23;6(1):154. doi: 10.1038/s41392-021-00549-9.
5
The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease.炎症性肠病背景下的人类小肠微生物组的组成和代谢潜能。
J Crohns Colitis. 2021 Aug 2;15(8):1326-1338. doi: 10.1093/ecco-jcc/jjab020.
6
Dynamics of the Salivary Microbiome During Different Phases of Crohn's Disease.唾液微生物组在克罗恩病不同阶段的动态变化。
Front Cell Infect Microbiol. 2020 Oct 6;10:544704. doi: 10.3389/fcimb.2020.544704. eCollection 2020.
7
The microbiome can predict mucosal healing in small intestine in patients with Crohn's disease.微生物群可以预测克罗恩病患者小肠的黏膜愈合情况。
J Gastroenterol. 2020 Dec;55(12):1138-1149. doi: 10.1007/s00535-020-01728-1. Epub 2020 Oct 16.
8
High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease.高通量测序揭示了与炎症性肠病相关的口腔微生物群失调情况。
Genomics. 2021 Jan;113(1 Pt 2):664-676. doi: 10.1016/j.ygeno.2020.09.063. Epub 2020 Oct 1.
9
Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.克罗恩病患者炎症性和近端非炎症性回肠的细菌黏膜相关微生物组。
Inflamm Bowel Dis. 2021 Jan 1;27(1):12-24. doi: 10.1093/ibd/izaa107.
10
The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases.黏膜微生物群组成与宿主基因表达之间的相互作用与炎症性肠病中英夫利昔单抗的反应相关。
Microorganisms. 2020 Mar 20;8(3):438. doi: 10.3390/microorganisms8030438.